Streetbeat News

Earnings

CSTM

Constellium has projected its FY23 adjusted EBITDA to be in the range of €700M - €720M.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:04 am

HLT

Hilton has provided its Q4 and FY23 adjusted EPS guidance. The company expects Q4 adjusted EPS to be between $1.51 and $1.56, compared to the estimated $1.56. For FY23, Hilton anticipates adjusted EPS to range from $6.04 to $6.09, against the estimated $6.07.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:03 am

TMO

Thermo Fisher Scientific has lowered its FY2023 adjusted EPS guidance from $22.28-22.72 to $21.50, and its sales guidance from $43.40B-44.00B to $42.7B. This is due to the current macroeconomic environment.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:03 am

VRT

Vertiv has increased its FY23 revenue outlook to $6.83B - $6.85B, up from the previous $6.71B - $6.91B. The company also raised its adjusted EPS forecast to $1.69 - $1.73 from $1.54 - $1.64.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:02 am

CSTM

Constellium (NYSE:CSTM) reported Q3 earnings of $0.47 per share, beating the analyst consensus estimate of $0.45 by 4.44%. However, this is a 47.19% decrease from the same period last year. The company's quarterly sales were $1.86 billion, missing the analyst consensus estimate of $1.94 billion by 4.23%, and marking an 8.83% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:02 am

OC

Owens-Corning (NYSE:OC) reported Q3 adjusted earnings of $4.15 per share, beating the analyst consensus estimate of $3.82 by 8.64%. This is a 16.25% increase from the same period last year. However, the company's quarterly sales of $2.48 billion missed the analyst consensus estimate of $2.53 billion by 1.98%, a 1.94% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:02 am

HLT

Hilton's Q3 adjusted EPS matched estimates at $1.67, while total revenues of $2.673B exceeded the estimated $2.62B.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:01 am

TMO

Thermo Fisher Scientific reported Q3 earnings of $5.69 per share, beating the analyst consensus estimate of $5.61 by 1.43%. This is a 12.01% increase from the same period last year. However, the company's quarterly sales of $10.57 billion missed the analyst consensus estimate of $10.59 billion by 0.19%, marking a 1.00% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 10:00 am

VRT

Vertiv Holdings Co (VRT) has projected its Q4 FY23 sales to be between $1.828B and $1.853B, surpassing the consensus estimate of $1.82B. The company also expects its adjusted EPS to be between $0.48 and $0.52, higher than the consensus estimate of $0.47.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:59 am

VRT

Vertiv Hldgs (NYSE:VRT) reported Q3 adjusted earnings of $0.52 per share, beating the analyst consensus estimate of $0.44 by 18.18%. This is a 126.09% increase from the same period last year. However, the company's quarterly sales of $1.74 billion missed the analyst consensus estimate of $1.75 billion by 0.40%, though it's a 17.69% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:57 am